AWH (aspirawh.com) Company Net Assets

The market price for Aspira Women's Health (AWH) on GURU.Markets, as confirmed by the chart, is -0.01. Aspira Women's Health is developing OvaSuite decentralized diagnostic panels to identify oncogynecological risks while optimizing current algorithms. Business revenues are protected by an extensive network of partnerships with US laboratories and a variety of IT platforms. Financial stability relies on the demand for women's health tests, which is gradually increasing the transparency of future cash flows.

AWH aspirawh.com Book Capitalization (07/04/2022 - 04/26/2025)

Analytical breakdowns and data insights for company Aspira Women's Health Inc. (AWH)

- price and consensus price forecast:

Price Performance Chart Aspira Women's Health Inc|AWH - Price Target Chart

- market capitalization data:

Market Valuation Aspira Women's Health, Inc.|AWH - Enterprise Value

- book capitalization data:

Net Asset Value per Share Aspira Women's Health|AWH - Book Capitalization|Capitalization to Book Value Ratio aspirawh.com|AWH - Company Total Assets

- debt and liquidity data:

Total Debt to Capital Aspira Women's Health|AWH - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Aspira Women's Health, Inc.|AWH - Company Aggregate Debts|Debts to Book Capitalization Aspira Women's Health, Inc.|AWH - Company Long-Term Debt|Company Short-Term Debt Aspira Women's Health

Fundamental company valuation:Aspira Women's Health Inc - AWH

Flagship merchandise of Aspira Women's Health Inc

To stress-test positions, it is critical for an investor to reconcile market value with the actual net assets that form the business's internal foundation. The development of diagnostic IT platforms and the extensive network of laboratory contracts of Aspira Women's Health (AWH) drive the dynamics of the company's total book capitalization, reflecting the difference between all assets and liabilities of the issuer to assess the objective value of its property.

Competitor analysis